How Much Time Do You Have to Treat #ProstateCancer? | #MarkScholzMD #AlexScholz #PCRI
PCRI's Alex and medical oncologist Mark Scholz, MD, discuss the timing of prostate cancer growth and how much time a patient may have to research and decide upon a treatment plan. 0:08 How much time would a Gleason 9 or 10 patient have to decide their treatment? 5:11 Why are patients often pushed to treatment so quickly? 7:20 How should a patient go about asking their physician for more time? 9:07 How much time does a Gleason 6 patient have to decide on their treatment? 11:02 What does the treatment timing window look like for Gleason 7 patients? 12:43 Alex's closing remarks Don't know your stage? Take the quiz: visit http://www.prostatecancerstaging.org To learn more about prostate cancer, visit http://www.pcri.org Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors. The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs. #markscholzmd #alexscholz #pcri
#ProstateCancer Diagnosis Over 80 Years Old | #MarkScholzMD #AlexScholz | #PCRI
3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI
Optimal Duration of Hormone Therapy For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI
Gleason 7 (4+3) #prostatecancer Treatments and Side Effects | #markscholzmd | PCRI
14 Years: #ProstateCancer & Active Surveillance | Bill Manning, Director of @ASPI
Gleason 3+4 vs 4+3: Which One Is More Dangerous?
How MPS2 Determines if a Prostate Biopsy is necessary I Jeff Tosoian, MD –148
Understanding #ProstateCancer Prognosis | #MarkScholzMD #AlexScholz #PCRI
Gleason 6 #ProstateCancer 101 | #MarkScholzMD #AlexScholz #PCRI
Most Men with Prostate Cancer are Choosing This Instead
Is Watchful Waiting The Right Thing To Do When You Have Prostate Cancer?
Gleason Score 8 vs Lower Scores | What's The Real Difference?
Treating Micro-Metastatic #ProstateCancer Disease | #MarkScholzMD #AlexScholz #PCRI
Prostate Cancer: What You NEED To Know
Stop Blind Biopsies: Near-Perfect Prostate Cancer Accuracy with Dr. Mark Emberton - EP 170
Why NOT radiation for prostate cancer?
Risk of Metastasis if you DON'T Treat Prostate Cancer
Do Prostate Biospies Spread #ProstateCancer? | #MarkScholzMD #AlexScholz #PCRI
Many Men Chose The Wrong Prostate Cancer Treatment: Here’s Why
